Erratum: Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III IRAKLIA Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.43, no.27, pp.3056, 2025 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 43 Issue: 27
- Publication Date: 2025
- Doi Number: 10.1200/jco-25-01767
- Journal Name: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, Gender Studies Database, International Pharmaceutical Abstracts, Veterinary Science Database, Nature Index
- Page Numbers: pp.3056
- Istanbul University Affiliated: Yes